Witold Czerwinski, MD
Psychiatry · Batesville, ARNPI 1710952270
Payments from drug & device makers
Across 63 payments — averaging $15.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sunovion Pharmaceuticals Inc.$161
- Lundbeck LLC$158
- AbbVie$153
- Johnson & Johnson$132
- Otsuka America Pharmaceutical, Inc.$109
- Axsome Therapeutics, Inc.$58
- plus $176 from 7 others
What the payments were for
- Food & beverage$947100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sunovion Pharmaceuticals Inc. | 21 | $161 |
| Lundbeck LLC | 9 | $158 |
| AbbVie(2 entities) | 7 | $153 |
| Johnson & Johnson | 7 | $132 |
| Otsuka America Pharmaceutical, Inc. | 7 | $109 |
| Axsome Therapeutics, Inc. | 2 | $58 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $54 |
| Alkermes, Inc. | 2 | $39 |
| E.r. Squibb & Sons, L.L.C. | 1 | $24 |
| Teva Pharmaceuticals USA, Inc. | 1 | $18 |
| Idorsia Pharmaceuticals US Inc | 1 | $15 |
| Merck | 1 | $13 |
| Corium, LLC | 1 | $13 |
How this compares
$947 in reported general payments places this provider in the 65th percentile of 235 psychiatry providers in Arkansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Chlorpromazine Hcl | 25 | $16,917 |
| Paliperidone ErPaliperidone | 24 | $2,555 |
| Zaleplon | 53 | $1,514 |
| Aripiprazole | 40 | $1,346 |
| Divalproex Sodium | 57 | $1,301 |
| Ziprasidone Hcl | 18 | $1,104 |
| Hydroxyzine Pamoate | 47 | $814 |
| Memantine Hcl | 43 | $803 |
| Duloxetine Hcl | 55 | $667 |
| Quetiapine Fumarate | 51 | $590 |
| Eszopiclone | 33 | $580 |
| Trazodone Hcl | 95 | $499 |
| Gabapentin | 36 | $406 |
| Risperidone | 50 | $394 |
| Medroxyprogesterone Acetate | 15 | $320 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Batesville
- Leslie SmithLittle Rock$7.9M
- Gintaras AukstuolisLittle Rock$6.6M
- Robert BillingsleyFayetteville$5.9M
- Paul WylieLittle Rock$3.4M
- Robert WootenPine Bluff$945K
- Prasad PadalaNorth Little Rock$868K
- Tad TillemansLittle Rock$656K
- Steven KoryElm Springs$628K
- Renea HendersonLittle Rock$366K
- Ronald WautersSearcy$204K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.